Hemagen Diagnostics Financials

Hemagen Diagnostics Stock Summary

Hemagen Diagnostics competes with Prothena Plc, Akero Therapeutics, and Apellis Pharmaceuticals. Hemagen Diagnostics, Inc., a biotechnology company, provides human and veterinary clinical diagnostic solutions worldwide. The company was founded in 1985 and is based in Columbia, Maryland. Hemagen Diagnostics operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 15 people.

Hemagen Diagnostics Key Financial Ratios

Hemagen Diagnostics' financial ratios allow both analysts and investors to convert raw data from Hemagen Diagnostics' financial statements into concise, actionable information that can be used to evaluate the performance of Hemagen Diagnostics over time and compare it to other companies across industries.

Hemagen Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Hemagen Diagnostics's current stock value. Our valuation model uses many indicators to compare Hemagen Diagnostics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Hemagen Diagnostics competition to find correlations between indicators driving Hemagen Diagnostics's intrinsic value. More Info.Hemagen Diagnostics is one of the top stocks in return on asset category among its peers. It also is one of the top stocks in profit margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Hemagen Diagnostics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Hemagen Diagnostics' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Hemagen Diagnostics Market Pulse

Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

If you are still planning to invest in Hemagen Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hemagen Diagnostics' history and understand the potential risks before investing.